Tallinn Mayor Advocates Russian Coronavirus Vaccine

Tallinn Mayor Advocates Russian Coronavirus Vaccine
Tallinn Mayor Advocates Russian Coronavirus Vaccine

Video: Tallinn Mayor Advocates Russian Coronavirus Vaccine

Отличия серверных жестких дисков от десктопных
Video: COVID-19: Russia has begun to roll out vaccination in Sputnik V clinics 2023, January
Anonim
Image
Image

The Mayor of Tallinn, Mikhail Kylvart, in an interview with Postimees, advocated the use of the Russian Sputnik V coronavirus vaccine in Estonia, if its effectiveness is confirmed by local experts.

According to him, due to new outbreaks of coronavirus, the republic cannot hesitate with vaccination, and therefore it should not be guided by the opinion of the regulatory bodies of the European Union (EU) in this matter. “Residents of Estonia will not ask European institutions where the vaccine is. Our residents will ask the country and the Tallinn City Council about this,”explained Kõlvart.

He added that the issue of using "Sputnik V" in European countries is highly politicized, while the EU is not yet able to fully provide itself with the required number of vaccines. “If it can be obtained from Russia or China, then this opportunity should be used,” the mayor stressed.

Earlier, Estonian President Kersti Kaljulaid called the approval of Sputnik V by the EU regulatory authorities as a condition for the start of supply of the drug to the country. “We will give these vaccines to our people in a completely apolitical way,” the head of state said.

Vaccinations in Estonia began at the end of December 2020, but despite this, the incidence rates of COVID-19 in the republic remain one of the highest in Europe.

Sputnik V was developed by the Russian Gamaleya Research Center for Electrochemistry and became the world's first officially registered vaccine against coronavirus. It was created on the basis of adenovirus, in which the coronavirus gene is embedded. When it enters the cells, it forms proteins in them - they cause an immune response and promote the development of antibodies.

Popular by topic